-
Oct 27, 2023, 09:25 AM
by
Insights from over 4,000 consumer cough-tracking app users sheds light on those struggling with chronic cough and key characteristics of the condition that needs greater awareness and more treatment options.
Full story
-
Oct 27, 2023, 09:25 AM
by
Full story
-
Oct 27, 2023, 09:25 AM
by
Full story
-
Oct 27, 2023, 01:00 AM
by
User Not Found
Bio-IT World | In the latest episode of The Chain podcast, host Ben Hackel, Professor of Chemical Engineering & Materials Science at the University of Minnesota, speaks with Enkelejda “Ledi” Miho, Professor of Digital Life Sciences at the University of Applied Sciences Northwestern Switzerland FHNW, about the data challenges currently facing drug discovery, and how an adisciplinary approach would allow a more fruitful flow of ideas between indication silos, fueling discovery.
Full story
-
Oct 26, 2023, 09:16 AM
by
Full story
-
Oct 26, 2023, 09:16 AM
by
Ventric Health Receives FDA 510(k) Clearance for Vivio®
Full story
-
Oct 26, 2023, 09:16 AM
by
Full story
-
Oct 26, 2023, 09:16 AM
by
Vizgen announced the winners of its first MERSCOPE® Platform Grant Program. Open to researchers in Europe and North America, the grants were awarded to the researchers with the most innovative and impactful proposals in cancer research. Vizgen created the grant program to expand the reach of spatial genomics as an essential tool for academic research and the life science industry.
Grant winners Aveline Filliol, PhD, Lead Program Manager in the Scott Lowe’s lab at Memorial Sloan Kettering Cancer Center (MSK), and Marek Piprek, MD, PhD candidate, at the Chris Marine Lab at the VIB-KU Leuven Center for Cancer Biology in Leuven, Flemish Region, Belgium will receive a full Vizgen® Lab Services MERFISH study generated on the MERSCOPE Platform.
Full story
-
Oct 26, 2023, 09:16 AM
by
One of the world’s leading biotech companies Hongene has announced the creation of an expert advisory panel with leading international experts to drive forward their growth agenda and science-led innovation
Full story
-
Oct 26, 2023, 01:00 AM
by
User Not Found
Bio-IT World | NTT Corporation joins an agreement with BC Platforms AG, PRIME-R, and Bioxcellerator to develop the Japan Precision Medicine Platform (JPP), a secure information sharing platform for medical data designed to improve medical data analysis and medical research domestically across Japan; FDA grants Fast Track Designation for Aspen Neurosciencce Parkinson's disease treatment; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Full story
-
Oct 25, 2023, 09:02 AM
by
Incheon, S. Korea, October 25, 2023 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the third quarter of fiscal year 2023.
Full story
-
Oct 25, 2023, 09:02 AM
by
Full story
-
Oct 25, 2023, 09:02 AM
by
A new research report from cybersecurity consulting firm, NCC Group finds healthcare experienced an 86% increase in ransomware attacks in September over August. Overall, there was a record high number of ransomware attacks launched by cybercriminals in September, with 514 victims -- a 153% year-on-year rise from September, 2022. This increase was accompanied by the emergence of new threat actors, such as LostTrust and RansomedVC, who became some of the most active groups.
Full story
-
Oct 25, 2023, 09:02 AM
by
Compliance with global information security management standard strengthens customer trust
Full story
-
Oct 25, 2023, 01:00 AM
by
User Not Found
Bio-IT World | bioMérieux further invests in Oxford Nanopore’s in vitro diagnostics; Automata Technologies raises funds for lab automation; NVIDIA and others invest in Iambic Therapeutics (formerly Entos) for generative AI; and more.
Full story
-
Oct 24, 2023, 08:27 AM
by
Full story
-
Oct 24, 2023, 08:27 AM
by
Full story
-
Oct 24, 2023, 08:27 AM
by
Full story
-
Oct 24, 2023, 08:27 AM
by
Full story
-
Oct 24, 2023, 08:27 AM
by
Full story